UPDATE 1-US FDA warns St. Jude on heart device claims
* Claims for two heart devices draw objections
* Company says working to address FDA concerns
WASHINGTON May 18 (Reuters) - Device maker St Jude Medical Inc (STJ.N) made improper claims about two heart devices, U.S. regulators said in a letter to the company.
The Food and Drug Administration, in an April 23 letter, objected to statements made on a company website about the Epicor LP Cardiac Ablation System and the Epicor UltraCinch LP Ablation Device.
St. Jude spokeswoman Marisa Bluestone said the company is "working diligently to address the points raised in the warning letter and to resolve the FDA's concerns."
- Malaysian airplane investigators look at suicide as possible motive |
- Planning could hold key to disappearance of Flight MH370 |
- U.S., EU set sanctions as Putin recognizes Crimea "sovereignty" |
- Magnitude 4.4 earthquake rocks Los Angeles area
- Russian government admits economy in crisis as Ukraine weighs